LONDON PHARMA & CHEMICALS GROUP LTD
Get an alert when LONDON PHARMA & CHEMICALS GROUP LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-02-06 (in 9mo)
Last made up 2026-01-23
Watchouts
None on the register
Cash
£17M
+6.2% highest in 3 filed years
Net assets
£23M
+1.7% highest in 3 filed years
Employees
7
-12.5% lowest in 3 filed years
Profit before tax
£345K
-64.8% lowest in 3 filed years
Net assets
7-year trend · vs Industrials median
Accounts
7-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-05-31 | 2020-05-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | £2,054,397 | — | — | £661,820 | £587,012 | |
| Operating profit | — | — | £134,147 | — | — | -£199,963 | -£908,537 | |
| Profit before tax | — | — | £7,031,621 | — | — | £979,106 | £344,661 | |
| Net profit | — | — | £7,010,979 | — | — | £988,990 | £376,730 | |
| Cash | — | — | £7,654,464 | — | — | £16,406,039 | £17,428,081 | |
| Total assets less current liabilities | — | — | £20,143,298 | — | — | £25,240,671 | £25,559,246 | |
| Net assets | — | — | £17,584,520 | — | — | £22,719,505 | £23,096,235 | |
| Equity | £12,161,282 | £10,573,541 | £17,584,520 | — | — | £22,719,505 | £23,096,235 | |
| Average employees | — | — | 9 | — | — | 8 | 7 | |
| Wages | — | — | £215,634 | — | — | £612,688 | £643,915 | |
| Directors' remuneration | — | — | £106,381 | — | — | £428,814 | £454,706 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-11.3%
£661,820 £587,012
lowest in 3 filed years
-
Cash
+6.2%
£16,406,039 £17,428,081
highest in 3 filed years
-
Net assets
+1.7%
£22,719,505 £23,096,235
highest in 3 filed years
-
Employees
-12.5%
8 7
lowest in 3 filed years
-
Operating profit
-354.4%
-£199,963 -£908,537
lowest in 3 filed years
-
Profit before tax
-64.8%
£979,106 £344,661
lowest in 3 filed years
-
Wages
+5.1%
£612,688 £643,915
highest in 3 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-05-31 | 2020-05-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | 6.5% | — | — | -30.2% | -154.8% | |
| Net margin | — | — | — | — | — | 149.4% | 64.2% | |
| Return on capital employed | — | — | 0.7% | — | — | -0.8% | -3.6% | |
| Current ratio | — | — | — | — | — | 2.51x | 2.35x | |
| Interest cover | — | — | 5.93x | — | — | -2.78x | -9.74x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- LONDON PHARMA & CHEMICALS GROUP LTD 2011-07-04 → present
- LONDON PHARMA & CHEMICALS HOLDINGS LTD 2011-06-03 → 2011-07-04
- S & D PHARMA LIMITED 2003-02-11 → 2011-06-03
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Morris Palmer Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- LONDON PHARMA & CHEMICALS GROUP LTD · parent
- Chemgo AG 100%
- Chemgo SARL 100%
- F.I.T. Industries Limited 100%
- LPC Bulgaria OOD 60%
- ProTec Balkans EOOD 100%
- ProTec Botanica Ltd 85%
- ProTec Ingredia GmbH 80%
- ProTec Ingredia Limited 92%
- ProTec Nutra Limited 75%
- ProTec Polska Sp. z o.o. 99.6%
- S & D Pharma CZ, spol. s r.o. 100%
- S & D Pharma Logistics BG EOOD 100%
- S & D Pharma Limited 100%
- S & D Pharma SK s r.o. 97%
- INB GmbH 100%
- F.I.T. Bulgaria OOD 85%
Significant events
- “The results were impacted by an impairment provision of £600,000 made in respect of a group loan.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| L P C SECRETARIAL LIMITED | Corporate Secretary | 2011-05-17 | — | — |
| COUSINS, Kevin Mark | Director | 2023-07-06 | Jun 1969 | British |
| SANDLER, Jamie Andrew | Director | 2016-02-09 | Feb 1976 | British |
| STRAUS, Daniel Reuben | Director | 2003-02-11 | Apr 1972 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LONDON LAW SECRETARIAL LIMITED | Corporate Nominee Secretary | 2003-02-11 | 2003-02-11 |
| S & D SECRETARIES LIMITED | Corporate Secretary | 2003-02-14 | 2011-05-17 |
| EASTWOOD, Alan Edward | Director | 2012-01-06 | 2023-05-31 |
| LEEMANN, Christian | Director | 2012-01-06 | 2022-12-01 |
| NEMCOKOVA, Andrea | Director | 2007-06-01 | 2011-06-01 |
| STRAUS, Peter Frederick | Director | 2003-02-11 | 2011-12-03 |
| LONDON LAW SERVICES LIMITED | Corporate Nominee Director | 2003-02-11 | 2003-02-11 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| London Pharma & Chemicals Holdings Ltd | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 88 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-25 | AA | accounts | Accounts with accounts type full | |
| 2025-02-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-23 | AA | accounts | Accounts with accounts type full | |
| 2024-02-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-05 | AA | accounts | Accounts with accounts type full | |
| 2023-07-06 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-31 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-01 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-15 | AA | accounts | Accounts with accounts type full | |
| 2022-02-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-27 | AA | accounts | Accounts with accounts type full | |
| 2021-05-25 | AA | accounts | Accounts with accounts type full | |
| 2021-02-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-02-12 | AA01 | accounts | Change account reference date company previous shortened | |
| 2020-02-26 | AA | accounts | Accounts with accounts type full | |
| 2020-02-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2019-02-28 | AA | accounts | Accounts with accounts type full | |
| 2019-02-06 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.